8 result(s) for Melanoma
| PI Name | Protocol # | Title |
|---|---|---|
| Sancy Leachman | IRB00010561 | War on Melanoma: Enlisting a cohort of melanoma survivors and their families |
| Prakash Ambady | STUDY00016046 | Response Assessment to Pembrolizumab with Standard of Care Therapy in Oligometastatic Brain Tumors from Melanoma, and Glioblastoma Using Ferumoxytol Steady State Imaging– A Pilot Study |
| John Vetto | STUDY00017104 | DecisionDx-Melanoma 31-Gene Expression Profile Clinical Impact Study |
| Rajan Kulkarni | STUDY00017648 | VAPORHCS/OHSU J: Isolation and analysis of circulating tumor cells (CTCs) and nucleic acids from patient blood specimens |
| Matthew Taylor | STUDY00018687 | A Phase 3, Randomized, Open-label Study of NKTR-214 combined with Nivolumab Versus Nivolumab in Participants with Previously untreated Unresectable or Metastatic Melanoma |
| Dale Han | STUDY00019285 | A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination with Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma |
| Matthew Taylor | STUDY00019679 | ADJUVANT THERAPY WITH PEMBROLIZUMAB VERSUS PLACEBO IN RESECTED HIGHRISK STAGE II MELANOMA: A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY (KEYNOTE 716) |
| Matthew Taylor | STUDY00019746 | A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma |
You may also qualify for Phase 1 Program trials.